BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 depicts an exemplary overview of an imaging system capable of implementing the present invention;
FIG. 2 depicts an exemplary flowchart that describes a methodology of a preferred embodiment of the present invention;
FIG. 3 depicts an exemplary perfluorocarbon nanoparticle emulsion;
FIG. 4 depicts an exemplary cumulative distribution function histogram with upper 5% thresholding;
FIG. 5 depicts an exemplary flowchart that describes a methodology for a microbubble-based contrast agent imaging embodiment;
FIG. 6 depicts an exemplary flowchart that describes a methodology for an embodiment wherein heating is used to enhance performance;
FIG. 7 depicts a plot of contrast enhancement as a function of temperature for an information theoretic signal receiver and conventional signal receivers;
FIG. 8 illustrates “contact-facilitated” drug delivery that can be monitored through the use of the present invention; and
FIG. 9 illustrates images produced in accordance with the present invention showing contrast enhancement of targeted areas corresponding to a VX-2 tumor in a New Zealand white rabbit.